Drug Profile
Alprostadil + prazosin - VIVUS
Alternative Names: AlibraLatest Information Update: 10 Dec 2021
Price :
$50
*
At a glance
- Originator VIVUS
- Class Monounsaturated fatty acids; Prostaglandins; Quinazolines; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 18 Jan 2006 Discontinued - Phase-III for Erectile dysfunction in USA (Transurethral)
- 23 Nov 2001 Discontinued-preregistration for Erectile dysfunction in European Union (Transurethral)
- 03 Nov 2000 VIVUS has withdrawn its NDA filing pending discussions with the FDA